Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy. - Wikidata - awgldk - TriplyDB

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.

http://www.wikidata.org/entity/Q37507018

about

Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200 Exosomes for Immunoregulation and Therapeutic Intervention in Cancer Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm Antibody-Based Assays for Phenotyping of Extracellular Vesicles Exosomes as Novel Regulators of Adult Neurogenic Niches The potential of tumor-derived exosomes for noninvasive cancer monitoring Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer.Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs Isolation of High-Purity Extracellular Vesicles by Extracting Proteins Using Aqueous Two-Phase System.Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis.Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.Extracellular vesicle isolation and characterization: toward clinical application The biological significance and clinical applications of exosomes in ovarian cancer.Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma.Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study.Roles of microRNA-140 in stem cell-associated early stage breast cancer.Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.Tumor-Derived Exosomes and Their Role in Cancer Progression.Exosomes: From Functions in Host-Pathogen Interactions and Immunity to Diagnostic and Therapeutic Opportunities.Exosomes in Cancer Diagnostics Exosomes in cancer theranostic: Diamonds in the rough.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Role of exosomal proteins in cancer diagnosis Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression.Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin.Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside.The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect.Miniaturized Biomedical Sensors for Enumeration of Extracellular Vesicles

P2860

Q24616100-FB70B7A6-65B5-4D13-8272-04C145185525 Q26744193-6F3EBB03-737F-4487-A576-0FF4498F4A9D Q26768704-361AF644-6B06-476E-A1C9-CC2F811CB559 Q26771759-09AC4321-DFD3-4518-A717-2B1E42D752C6 Q26772836-735E0754-4452-4A70-BE9F-736792E4B5C3 Q26796396-A2C63449-A1B1-407A-ACE5-F729AD5E9372 Q28550734-5CE4FD66-E68F-459D-A2A3-1A0012F99321 Q33691489-9B053CA6-C895-42BC-BF9C-74A2E3A4726A Q34304788-B87E477C-0502-46CB-9EC5-BAECB7B48FD7 Q35668362-C7FF5D27-68F0-4889-9C23-8050332825E0 Q35763548-70CF62B5-588E-4038-8661-D05F7138176D Q36028740-861C0537-0E7F-402F-904E-396C375263F3 Q36511698-801CA013-01E2-49B3-8C92-870E0E982FBB Q36737951-E60BCC2F-6B31-4681-BD0E-0FD19D65AF3C Q37029851-D86FC2F7-1F91-4AAB-A3FA-5AFF9CF210C6 Q37073022-9B25DD2D-43AD-4855-8245-AECAAEFA4861 Q37086163-7ADAFD93-3BC2-4DB1-AC4A-1BEB434C7869 Q37654423-0487D12C-FB46-4B78-8C26-4869CEE91D42 Q37716375-41F116ED-B2F7-4A1A-A576-D9DDAD1CF6E9 Q38271600-FFD3F062-A74E-4B0C-BFA9-332BEC350656 Q38713584-0F291D9B-9E0A-4290-8E39-603E0890FC5B Q38818439-40A96413-7503-491A-890B-4D51FCA56BB8 Q38947856-C06E6880-70A9-4D16-8B40-4C0ECDA06AFE Q39085664-E49F539B-D229-4002-BF81-09CDABF17B92 Q39122582-174845D8-0E5C-4262-9B9B-0F19D5B0FC0B Q41006936-F525A08C-2577-453F-A225-C87E5D49BD56 Q41556414-D907B5E4-049A-4F81-990B-3AA9698717D6 Q41599721-A01F907B-4475-4B4C-9877-A55A4F751AFE Q47105314-49861CFA-5FE5-4A33-A9C0-86E5153D3610 Q47134018-AAA7EC66-5F87-4FE1-B707-D25DE2EF4DAF Q47303843-CE9E4CCA-FBF0-41E0-A505-F88632372549 Q47622685-38AEB240-DE33-401E-95C7-BA3D9BBA6BC7 Q52589944-20E40CA3-E6B9-42A4-AE67-7999B8D483C0 Q55111008-92A07DB1-915D-472F-90A1-564AD9DE24E7 Q57785942-86C5C80C-F55C-424A-8C05-249458FF6526

P2860

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.

http://www.wikidata.org/entity/Q37507018

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Exosomes in Plasma of Patients ...... ssion and Response to Therapy.

@en

Exosomes in Plasma of Patients ...... ssion and Response to Therapy.

@nl

type

label

Exosomes in Plasma of Patients ...... ssion and Response to Therapy.

@en

Exosomes in Plasma of Patients ...... ssion and Response to Therapy.

@nl

prefLabel

Exosomes in Plasma of Patients ...... ssion and Response to Therapy.

@en

Exosomes in Plasma of Patients ...... ssion and Response to Therapy.

@nl

P1433

Q37507018-A32266AA-8C4D-4698-95B4-78145FF2A83C

P1476

Q37507018-36D97151-B8DA-4F47-B497-3B55CAD89504

P2093

Q37507018-20B098B3-8A99-444D-AD2F-D5CD9D1CA661

Q37507018-8B85138B-A2C6-492E-A0C4-DCF81CA5D4D6

Q37507018-A566EE37-6AA8-4ADA-9466-B0B9FB15528E

Q37507018-B108F1CB-DA57-44A9-944A-83D865482730

Q37507018-B45850F6-8AFC-4A93-864F-88123B484879

Q37507018-B4DD5AE6-2BD8-4470-81EE-8F553B7D6E56

Q37507018-DB168D92-3077-4463-BB96-E1DAEC084B19

Q37507018-DB66E156-4C28-447C-8332-6771A7B0DE4C

Q37507018-DC9FE3A1-A09D-4F47-9B6D-D4109B1AD877

Q37507018-FC9AE56C-153D-49BD-94FE-D1F6EA982E83

P2860

Q37507018-0A8B822D-9782-4CBD-AD67-630879F69E42

Q37507018-0BE22010-4671-4858-BB07-D4963D001881

Q37507018-1CB82AC0-A52E-4BEC-BB71-C6A46D0D1F76

Q37507018-30E0A685-7E18-41E7-AD91-2052BD37555B

Q37507018-3858C35E-96F7-4D75-B17A-1073E7C8272D

Q37507018-4DD20437-0966-4047-8A50-299FEB25D2F9

Q37507018-52130DBB-5EB1-402C-88C2-D04FA8A60DAD

Q37507018-74EC1324-A55F-4569-BEC4-394488265069

Q37507018-798E61A3-B6C0-4B32-BB8E-9943D2E08338

Q37507018-7B3E59DD-79E3-4962-951E-4E336A36A886

P304

Q37507018-48E3146F-FDE1-4608-A7E1-8C934A5302AE

P31

Q37507018-877C2A66-08DF-4253-9138-3982C84A8D62

P356

Q37507018-31D5C82F-2519-4095-8CEB-6CA5B7DB5A4D

P478

Q37507018-1EFB8DA2-41DD-4496-88D2-24BD31AF2ED9

P50

Q37507018-94C28346-3463-4057-A16E-C97CF181003F

P577

Q37507018-1D135A3B-9078-48FE-AF29-C34187A24FC9

P698

Q37507018-56292F27-8AD5-4718-BCDD-252E99BABC50

P921

Q37507018-6DACA93A-0210-44E1-B958-D87143322664

Q37507018-E098E667-9155-4A2A-9365-CF7800FDA54A

P932

Q37507018-3A8EDAEB-7802-4AAF-9F23-249AA6569970

P356

2161-0932.S4-003

P1433

Gynecology & obstetrics (Sunnyvale, Calif.)

P1476

Exosomes in Plasma of Patients ...... ssion and Response to Therapy.

@en

P2093

Andrzej Nowakowski

http://www.w3.org/2001/XMLSchema#string

Dariusz Szpurek

http://www.w3.org/2001/XMLSchema#string

Hanna Drzewiecka

http://www.w3.org/2001/XMLSchema#string

Magdalena Derbis

http://www.w3.org/2001/XMLSchema#string

Marcin Michalak

http://www.w3.org/2001/XMLSchema#string

Marek Spaczynski

http://www.w3.org/2001/XMLSchema#string

Marta Szajnik

http://www.w3.org/2001/XMLSchema#string

Paulina Patalas

http://www.w3.org/2001/XMLSchema#string

Theresa L Whiteside

http://www.w3.org/2001/XMLSchema#string

Włodzimierz Baranowski

http://www.w3.org/2001/XMLSchema#string

P2860

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes.

Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.

High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients.

Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer

P304

3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4172/2161-0932.S4-003

http://www.w3.org/2001/XMLSchema#string

P478

Suppl 4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24466501

http://www.w3.org/2001/XMLSchema#string

P921

P932

3899646

http://www.w3.org/2001/XMLSchema#string